Table 1.
Predicting factors for receiving antitussive agents following angiotensin-converting enzyme inhibitor (ACEi) initiation over the opposite prescription order, total study population of 1054
| Variable | n (%) | Odds ratio | 95% confidence interval |
|---|---|---|---|
| Date of ACEi prescription (per month) | 1.00 | (0.99, 1.00) | |
| Age (per year) | 1.00 | (0.99, 1.01) | |
| Female gender | 646 (61.3) | 1.45 | (1.11, 1.90) |
| Recorded use of co-medication | |||
| Obstructive airway disease | 122 (11.6) | 1.18 | (0.78, 1.80) |
| Diabetes mellitus | 198 (18.8) | 1.40 | (0.99, 1.98) |
| AT-2 antagonists | 23 (2.2) | 0.93 | (0.39, 2.26) |
| β-Blockers | 358 (34.0) | 1.01 | (0.76, 1.33) |
| Calcium channel antagonists | 110 (10.4) | 1.52 | (0.96, 2.42) |
| Diuretics | 298 (28.3) | 0.84 | (0.63, 1.14) |